Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-Operative Steroids After Sleep Surgery
NCT06818981Phase 2Withdrawn
- Sponsor
- Medical University of South Carolina
- Start
- Jul 2026
- Primary completion
- Jul 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexamethasone in obstructive sleep apnea (OSA) (4 arms), sponsored by Medical University of South Carolina. Primary endpoint: Pain control at 2 weeks. Planned start Jul 2026; status: withdrawn.
02
Drugs
dexamethasone
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT06818981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06818981.